Where does RefleXion Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), RefleXion Medical, Inc. ranks #5,312 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does RefleXion Medical, Inc. hold?

RefleXion Medical, Inc. holds 65 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is RefleXion Medical, Inc.'s Innovation Score?

RefleXion Medical, Inc. has an Innovation Score of 50.3 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is RefleXion Medical, Inc.'s patent grant rate increasing or decreasing?

RefleXion Medical, Inc.'s recent grant velocity is +318% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for RefleXion Medical, Inc.'s patents?

RefleXion Medical, Inc.'s patents average 27.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the RefleXion Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

RefleXion Medical, Inc.

Q: What technology areas does RefleXion Medical, Inc. focus on?

RefleXion Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 60 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 65 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Reflexion ranks #5,312 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 7 technology areas.

#5,312
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.3/100): 27.9
avg claims per patent: +318%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5312 · US Corporation #5,312 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,312/49,997
PHOTO-FINISH Primetals Germany
CPC-NARROW A61N · 7 areas
INNOV-PAR 50.3/100
CLAIMS-DENSE 27.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +318% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Primetals Technologies Germany GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
A123 Systems · near

50
Nantero · near

50
RefleXion Medical · this assignee

50
Samsung Heavy IND · near

50
SSenStone · near

50
3D Lighting… · lowest

7

What this shows Reflexion's Innovation Score is 50.3/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Reflexion's grants concentrate

RefleXion Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 92.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (13 grants) versus a trough of 1 in 2015. By volume, Reflexion sits between Primetals Technologies Germany GMBH and SDS Asia Limited, BVI #1748971.

Reflexion's three-year grant acceleration

RefleXion Medical, Inc. shows 31 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Primetals Germany

65
Provisur

65
Putzmeister Engin…

65
ReifenhÄUSER & KG…

65
Relign

65
Reno

65
Saes Getters S P A

65
SDS Asia BVI #174…

65
Reflexion Medical ◀

65

What this shows RefleXion holds 65 patents at rank #5,312, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near RefleXion

By rank, the assignees closest to #5,312 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in RefleXion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for RefleXion, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Samsung Heavy IND. Co., Ltd. 50 Nantero, Inc. 50 A123 Systems LLC 50 SSenStone Inc. 50

Similar claim depth

Nearest assignees by average claims per patent (27.9 here).

Magna Mirrors of America, Inc. 28.0 avg RealD Spark, LLC 28.0 avg Sight Sciences, Inc. 28.0 avg Hayward Industries, Inc. 27.7 avg

Reflexion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

RefleXion Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.5%
2016	1	1.5%
2017	4	6.2%
2018	2	3.1%
2019	3	4.6%
2020	9	13.8%
2021	6	9.2%
2022	9	13.8%
2023	9	13.8%
2024	13	20.0%
2025partial year	8	12.3%

Which technologies does RefleXion Medical, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 60

A61B - DIAGNOSIS; SURGERY; Identification 31

G01T - Measurement OF Nuclear OR X-radiation 23

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 5

G06T - Image Data Processing OR Generation, IN General 2

G06V - Image OR Video Recognition OR Understanding 1

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#5,312

of 49,997 tracked assignees

Innovation Score

50.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

RefleXion Medical, Inc.'s patent record in context - here's where to go next.

RefleXion Medical, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 92.3% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #5,312 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare RefleXion Medical, Inc. against Primetals Technologies Germany GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.